
Madrigal Pharmaceuticals to Release Fourth-Quarter and Full-Year 2024 Financial Results and Host Webcast on February 26, 2025
CONSHOHOCKEN, Pa., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) announced today that it will release its fourth-quarter and full-year 2024 financial results on Wedne...
- February 12, 2025 05:00 AM PST
- EODHD

KALA BIO Announces Chief Executive Officer Transition
ARLINGTON, Mass., Feb. 12, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative...
- February 12, 2025 05:00 AM PST
- EODHD

NCR Atleos Announces Date of Fourth Quarter and Full Year 2024 Earnings Conference Call
ATLANTA, February 12, 2025--(BUSINESS WIRE)--NCR Atleos Corporation (NYSE: NATL) ("Atleos") will release fourth quarter and full year 2024 financial results after the market close on Monday, March 3,...
- February 12, 2025 05:00 AM PST
- EODHD